Prostate-specific membrane antigen (PSMA)-mediated laminin proteolysis generates a pro-angiogenic peptide
Jazyk angličtina Země Německo Médium print-electronic
Typ dokumentu časopisecké články
Grantová podpora
R01 CA161056
NCI NIH HHS - United States
P01 HL070694
NHLBI NIH HHS - United States
PubMed
27387982
DOI
10.1007/s10456-016-9521-x
PII: 10.1007/s10456-016-9521-x
Knihovny.cz E-zdroje
- Klíčová slova
- Angiogenesis, Extracellular matrix, GCPII, Laminin, PSMA, Peptides,
- MeSH
- angiogenní proteiny metabolismus MeSH
- antigeny CD29 metabolismus MeSH
- antigeny povrchové genetika metabolismus MeSH
- buněčná adheze MeSH
- dipeptidy metabolismus MeSH
- endoteliální buňky pupečníkové žíly (lidské) MeSH
- endoteliální buňky cytologie metabolismus MeSH
- fyziologická neovaskularizace MeSH
- glutamátkarboxypeptidasa II genetika metabolismus MeSH
- hydrolýza MeSH
- laminin metabolismus MeSH
- lidé MeSH
- mutantní proteiny genetika metabolismus MeSH
- peptidové fragmenty metabolismus MeSH
- proteolýza MeSH
- substrátová specifita MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- Názvy látek
- angiogenní proteiny MeSH
- antigeny CD29 MeSH
- antigeny povrchové MeSH
- dipeptidy MeSH
- FOLH1 protein, human MeSH Prohlížeč
- glutamátkarboxypeptidasa II MeSH
- isospaglumic acid MeSH Prohlížeč
- laminin MeSH
- mutantní proteiny MeSH
- peptidové fragmenty MeSH
Prostate-specific membrane antigen (PSMA) is a membrane-bound glutamate carboxypeptidase expressed in a number of tissues. PSMA participates in various biological functions depending on the substrate available in the particular tissue; in the brain, PSMA cleaves the abundant neuropeptide N-acetyl-aspartyl-glutamate to regulate release of key neurotransmitters, while intestinal PSMA cleaves polyglutamated peptides to supply dietary folate. PSMA expression is also progressively upregulated in prostate cancer where it correlates with tumor progression as well as in tumor vasculature, where it regulates angiogenesis. The previous research determined that PSMA cleavage of small peptides generated via matrix metalloprotease-mediated proteolysis of the extracellular matrix protein laminin potently activated endothelial cells, integrin signaling and angiogenesis, although the specific peptide substrates were not identified. Herein, using enzymatic analyses and LC/MS, we unequivocally demonstrate that several laminin-derived peptides containing carboxy-terminal glutamate moieties (LQE, IEE, LNE) are bona fide substrates for PSMA. Subsequently, the peptide products were tested for their effects on angiogenesis in various models. We report that LQ, the dipeptide product of PSMA cleavage of LQE, efficiently activates endothelial cells in vitro and enhances angiogenesis in vivo. Importantly, LQE is not cleaved by an inactive PSMA enzyme containing an active site mutation (E424S). Endothelial cell activation by LQ was dependent on integrin beta-1-induced activation of focal adhesion kinase. These results characterize a novel PSMA substrate, provide a functional rationale for the upregulation of PSMA in cancer cells and tumor vasculature and suggest that inhibition of PSMA could lead to the development of new angiogenic therapies.
Department of Biology College of Liberal Arts and Science Lipscomb University Nashville TN 37204 USA
Department of Molecular and Comparative Pathobiology Johns Hopkins University Baltimore MD 21205 USA
Department of Neurology Johns Hopkins University Baltimore MD 21205 USA
Johns Hopkins Drug Discovery Johns Hopkins University Baltimore MD 21205 USA
Citace poskytuje Crossref.org